To the Editor, I read the report by Ridtitid et al. concerning the outcome of second interventions for occluded metallic stents in patients with malignant biliary obstruction with a great interest [1] . Ridtitid et al. concluded that ''A second SEMS insertion in occluded SEMS provides a significantly longer patency time than PS and PTBD'' [1] . Indeed, Lee et al. noted that ''Metallic stents showed a favorable patency rate with regard to patient survival'' [2] . I agree that the study by Ridtitid et al. might provide evidence to support the clinical usefulness of SEMS. However, I have some additional concerns about the work. First, it is questionable whether SEMS can contribute to a better quality of life compared with PS and PTBD. Second, although SEMS can last for a longer time, its cost-effectiveness is still questionable. Third, as Ridtitid et al. noted , there are many kinds of malignant biliary obstruction; therefore, more subjects for each specific subgroup might be needed to strengthen the conclusion.
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